<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0013648"><a href="http://purl.obolibrary.org/obo/MONDO_0013648">MONDO:0013648</a></h3>
<p><strong>Label:</strong> familial progressive hyperpigmentation</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0007771">MONDO:0007771</a> (hyperpigmentation with or without hypopigmentation, familial progressive),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_145250">OMIM:145250</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79146">Orphanet:79146</a>, <a href="http://www.orpha.net/ORDO/Orphanet_280628">Orphanet:280628</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and <a href="http://purl.obolibrary.org/obo/HP_0011368">HP:0011368</a> (Epidermal thickening) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and <a href="http://purl.obolibrary.org/obo/HP_0001072">HP:0001072</a> (Thickened skin) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000962">HP:0000962</a> (Hyperkeratosis) and <a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002960">HP:0002960</a> (Autoimmunity))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000708">HP:0000708</a> (Behavioral abnormality))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and <a href="http://purl.obolibrary.org/obo/HP_0011368">HP:0011368</a> (Epidermal thickening) and (not (<a href="http://purl.obolibrary.org/obo/HP_0025032">HP:0025032</a> (Abnormality of digestive system physiology))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and <a href="http://purl.obolibrary.org/obo/HP_0011368">HP:0011368</a> (Epidermal thickening) and (not (<a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and <a href="http://purl.obolibrary.org/obo/HP_0011368">HP:0011368</a> (Epidermal thickening) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011138">HP:0011138</a> (Abnormality of skin adnexa morphology))) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001045">HP:0001045</a> (Vitiligo) and <a href="http://purl.obolibrary.org/obo/HP_0011368">HP:0011368</a> (Epidermal thickening) and (not (<a href="http://purl.obolibrary.org/obo/HP_0008373">HP:0008373</a> (Puberty and gonadal disorders))) 66.67%</li>
</ul>
</body>
</html>
